3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
18
Carcinoma, Non-Small-Cell Lung
15
Lung Neoplasms
7
Breast Neoplasms
7
Triple Negative Breast Neoplasms
6
Neoplasms
5
Neoplasm Metastasis
5
Colorectal Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Head and Neck Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma
2
Vaccinia
1
Uterine Cervical Neoplasms
1
Squamous Non-small Cell Lung Cancer
1
Rectal Neoplasms
1
Pathologic Complete Response
1
Pancreatic Ductal Adenocarcinoma
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Melanoma
1
Locally Advanced Pancreatic Cancer
1
Gastric Adenocarcinoma
1
Gallbladder Cancer Unresectable
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Colonic Neoplasms
1
Carcinoma, Pancreatic Ductal
1
Brain Neoplasms
1
Anal Cancer Metastatic
1
Interventions
X-Rays
4
Phantoms, Imaging
4
Nuclear Medicine Department, Hospital
4
Magnetic Resonance Spectroscopy
4
Vincristine
3
Temozolomide
3
Specimen Handling
3
Irinotecan
3
Cyclophosphamide
3
Biopsy
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
larotrectinib
2
ivosidenib
2
ensartinib
2
Radiotherapy
2
temsirolimus
1
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
fludarabine
1
erdafitinib
1
cabozantinib
1
atezolizumab
1
Vinorelbine
1
Vemurafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdomyosarcoma
×
130-nm albumin-bound paclitaxel
×
30 days
×
Clear all
No trials found.